Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

Bayer AG. (10/1/14). "Press Release: Strengthening the Soybean Business. Bayer CropScience the Seed Business of Granar S.A.". Monheim.

Organisations Organisation Bayer CropScience AG
  Group Bayer (Group)
  Organisation 2 Granar S.A. (Igra Semillas)
Products Product soybean (seeds)
  Product 2 AGRI LIFE SCIENCES
     


Bayer CropScience announced today that it has entered into an agreement to purchase the seed business of Granar S.A., based in Encarnacion, Paraguay. The private company, founded in 2001, specializes in the breeding, production and marketing especially of improved soybean seeds adapted to the growing conditions that prevail in subtropical regions. Granar S.A. has a strong presence in Paraguay and Uruguay and a growing presence in Brazil. It employs approximately 50 people. Financial details were not disclosed.

Especially important is the acquisition of the Igra Semillas brand of Granar S.A. Since it was founded, Granar S.A. and its Igra Semillas brand have established a solid presence in the Paraguayan market.

Granar S.A. will continue to be responsible for marketing Igra seed in 2014. Bayer will start selling the Igra Semillas brand from 2015. This important acquisition will enable Bayer CropScience to enter the soybean seed market in Paraguay for the first time, putting the company in a position to offer farmers a complete package for this crop.

“Soybeans are a crop with great strategic importance for the region and for Bayer CropScience. This acquisition gives us access to quality germplasm for future variety and trait development,” said Eduardo Estrada, Head of Bayer CropScience Latin America. “With our current portfolio of products and with the Granar S.A. added-value varieties, we now find ourselves in a position where we can provide Paraguayan soybean farmers with a complete range of solutions which includes seed, crop protection products and services.”

For Bayer CropScience, this acquisition represents one more step towards achieving an international platform of excellence in soybean seed, and it also underscores the importance of the Latin American region in this context. Over the past three years, the company has announced various acquisitions in Latin America, including the germplasm bank of Agropastoril Melhoramento, the soybean companies Wehrtec and SoyTech, the plant breeding technology of CVR (all in Brazil), and the purchase of FN Semillas S.A. in Argentina.

“Our acquisitions mean that we will be able to offer Latin American farmers the most modern developments in our portfolio of soybean traits in highly competitive local varieties,” said Estrada. “Building on an expanded portfolio of soybean varieties and on our international-level research on plant traits, we will be able to provide farmers with a wide range of maturity levels, adopted to the diverse growing conditions which prevail in the region.”


About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,819 million (2013) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 22,400 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

Find more information at www.bayercropscience.com.


Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

   
Record changed: 2017-04-02

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px




» top